Applied Dna Sciences (NASDAQ:BNBX) Issues Earnings Results

Applied Dna Sciences (NASDAQ:BNBX) announced its quarterly earnings data on Thursday. The company reported ($2.08) earnings per share for the quarter, Zacks reports. The company had revenue of $0.57 million during the quarter. Applied Dna Sciences had a negative net margin of 399.91% and a negative return on equity of 487.84%.

Applied Dna Sciences Stock Up 5.7%

Applied Dna Sciences stock opened at $0.85 on Friday. Applied Dna Sciences has a 52 week low of $0.74 and a 52 week high of $131.25. The firm has a market cap of $3.69 million, a PE ratio of 0.00 and a beta of 0.57.

Wall Street Analyst Weigh In

Separately, Weiss Ratings began coverage on shares of Applied Dna Sciences in a research note on Monday, January 26th. They set a “sell (e+)” rating on the stock. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.

Applied Dna Sciences Company Profile

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.